The Challenge of the Surgically Ineligible: Left Main PCI with Reduced EF – A Case from PROTECT IV RCT

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Consultant Fee/Honoraria/Speaker's Bureau (Personal) - Abbott Vascular; Boston Scientific Corporation; Abiomed; Biotronik; Medtronic; Cardiovascular Systems, Inc
• Grant Support/Research Contract (Both) - Abiomed